Nutrition Therapy in Improving Immune System in Patients With Bladder Cancer That Can Be Removed by Surgery (NCT03757949)
A Randomized Phase III Double Blind Clinical Trial Evaluating the Effect of Immune-Enhancing Nutrition on Radical Cystectomy Outcomes
🩺 Plain-English Summary (8th-Grade Level)
This phase III trial studies how well nutrition therapy works in improving immune system in patients with bladder cancer that can be removed by surgery. Improving nutrition before and after surgery may reduce the infections and other problems that sometimes occur after surgery.
Who can join: Review the eligibility criteria below.
Location: City of Hope Comprehensive Cancer Center — Duarte, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (46 Sites)
Showing the first 25 of 46 sites.
- City of Hope Comprehensive Cancer Center — Duarte, California
- Los Angeles County-USC Medical Center — Los Angeles, California
- USC / Norris Comprehensive Cancer Center — Los Angeles, California
- USC Norris Oncology/Hematology-Newport Beach — Newport Beach, California
- Keck Medical Center of USC Pasadena — Pasadena, California
- University of Colorado Hospital — Aurora, Colorado
- Mayo Clinic in Florida — Jacksonville, Florida
- Northwestern University — Chicago, Illinois
- Cancer Care Specialists of Illinois - Decatur — Decatur, Illinois
- Decatur Memorial Hospital — Decatur, Illinois
- University of Kansas Clinical Research Center — Fairway, Kansas
- University of Kansas Cancer Center — Kansas City, Kansas
- University of Kansas Hospital-Indian Creek Campus — Overland Park, Kansas
- University of Kansas Hospital-Westwood Cancer Center — Westwood, Kansas
- LSU Healthcare Network / Metairie Multi-Specialty Clinic — Metairie, Louisiana
- Maine Medical Center-Bramhall Campus — Portland, Maine
- Maine Medical Center- Scarborough Campus — Scarborough, Maine
- Saint Joseph Mercy Hospital — Ann Arbor, Michigan
- IHA Hematology Oncology Consultants-Brighton — Brighton, Michigan
- Saint Joseph Mercy Brighton — Brighton, Michigan
- IHA Hematology Oncology Consultants-Canton — Canton, Michigan
- Saint Joseph Mercy Canton — Canton, Michigan
- IHA Hematology Oncology Consultants-Chelsea — Chelsea, Michigan
- Saint Joseph Mercy Chelsea — Chelsea, Michigan
- Henry Ford Hospital — Detroit, Michigan
📞 Contact the Study Coordinator
Phone: (800) 826-4673
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Bladder Carcinoma
- Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers — Los Angeles, California
- Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers — Duarte, California
- Bladder Bank (a Prospective Banking Study) — Rochester, Minnesota
- ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation — Birmingham, Alabama
- The Vanguard Study: Testing a New Way to Screen for Cancer — Pleasanton, California
Explore by condition: All Bladder Carcinoma clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.